Sold??? The only ones selling Cytodyn, Inc. are shorts and they'll have to replace those shares - plus pay substantial interest on the shares while they're borrowed.
We're buying on dips, from the dips that sell. There's a number of folks accumulating and that should make it even harder for shorts to cover.
The DSMC of October 20, 2020, was very positive re the CD12 Phase2b/3 trial. "The DSMC recommends the trial continue without modification to achieve the primary endpoint..."
The PROBLEM is, with almost 400 patient count involved and numerous measurements (beyond fatality) that have to be collected, analyzed, organized, reported, etc. in the form assimilable by the FDA, takes time.
Leronlimab is worth waiting for...but in the meantime people are dying and suffering. This has to be done correctly and get into physicians' hands!